Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2YfhBcy
